Semler Scientific, Inc.
General ticker "SMLR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $270.7M (TTM average)
Semler Scientific, Inc. does not follow the US Stock Market performance with the rate: -7.8%.
Estimated limits based on current volatility of 3.9%: low 19.70$, high 21.28$
Factors to consider:
- Total employees count: 79 (-14.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Strategic risks and growth management, Customer adoption, Reimbursement risks, Labor/talent shortage/retention, Distribution network management
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [39.97$, 67.71$]
- 2025-12-31 to 2026-12-31 estimated range: [36.36$, 62.81$]
Financial Metrics affecting the SMLR estimates:
- Positive: with PPE of 11.3 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 37.19 > 18.34
- Positive: 0 < Operating cash flow per share per price, % of 5.38
- Positive: Shareholder equity ratio, % of 96.21 > 64.37
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SMLR quotes
Long-term SMLR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $56.69MM | $68.18MM | $56.29MM |
| Operating Expenses | $39.48MM | $45.93MM | $35.36MM |
| Operating Income | $17.20MM | $22.26MM | $20.93MM |
| Non-Operating Income | $0.49MM | $1.84MM | $26.95MM |
| R&D Expense | $0.00MM | $5.77MM | $4.79MM |
| Income(Loss) | $17.69MM | $24.10MM | $47.88MM |
| Taxes | $3.37MM | $3.52MM | $6.99MM |
| Profit(Loss)* | $14.32MM | $20.58MM | $40.90MM |
| Stockholders Equity | $55.68MM | $71.80MM | $230.75MM |
| Inventory | $0.47MM | $0.45MM | $0.36MM |
| Assets | $62.69MM | $78.06MM | $239.83MM |
| Operating Cash Flow | $17.46MM | $21.33MM | $24.41MM |
| Capital expenditure | $2.16MM | $0.83MM | $189.75MM |
| Investing Cash Flow | $-26.84MM | $18.40MM | $-189.98MM |
| Financing Cash Flow | $-4.94MM | $-5.41MM | $117.19MM |
| Earnings Per Share** | $2.13 | $3.06 | $5.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.